A Multicenter, Open-label, Single-arm Study to Evaluate the Pharmacokinetics, Efficacy, and Safety of Brivaracetam in Neonates With Repeated Electroencephalographic Seizures
Not yet recruiting
Phase of Trial: Phase II/III
Latest Information Update: 22 Mar 2018
At a glance
- Drugs Brivaracetam (Primary) ; Brivaracetam (Primary)
- Indications Neonatal seizures
- Focus Pharmacokinetics
- Acronyms PETITE
- Sponsors UCB Biopharma
- 19 Mar 2018 Planned End Date changed from 20 Dec 2019 to 20 Nov 2020.
- 19 Mar 2018 Planned primary completion date changed from 18 Oct 2019 to 1 Oct 2020.
- 19 Mar 2018 Planned initiation date changed from 15 Nov 2017 to 1 Mar 2018.